Literature DB >> 24759145

Differential roles of tissue factor and phosphatidylserine in activation of coagulation.

Henri M H Spronk1, Hugo ten Cate2, Paola E J van der Meijden2.   

Abstract

It has been suggested that the main physiological trigger of coagulation, tissue factor, possesses limited procoagulant activity and occurs in an inactive or so-called encrypted state. For the conversion of encrypted into decrypted tissue factor with sufficient procoagulant activity, four distinct models have been proposed: 1; dimer formation, 2; lipid rafts, 3; disulfide bonds, and 4; phosphatidylserine exposure. Pro and cons can be given for each of these mechanisms of tissue factor encryption/decryption, however, it seems most likely that two or more mechanisms act together in activating the procoagulant activity. The exposure of phosphatidylserine in the outer layer of cell membranes supports coagulation through enhanced formation of the tenase (factors IXa, VIIIa and X) and prothrombinase (factors Xa, Va and prothrombin) complexes. The proposed role for phosphatidylserine in decryption of tissue factor could contribute to the correct orientation of the tissue factor - factor VII complex. Overall, the contribution of both tissue factor and phosphatidylserine to coagulation seems distinct with tissue factor being the physiological activator and phosphatidylserine the driving force of propagation of coagulation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759145     DOI: 10.1016/j.thromres.2014.03.022

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  15 in total

1.  Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.

Authors:  Lauren E Witter; Erika J Gruber; Fabian Z X Lean; Tracy Stokol
Journal:  Am J Vet Res       Date:  2017-01       Impact factor: 1.156

2.  Elucidating mechanisms of toxicity using phenotypic data from primary human cell systems--a chemical biology approach for thrombosis-related side effects.

Authors:  Ellen L Berg; Mark A Polokoff; Alison O'Mahony; Dat Nguyen; Xitong Li
Journal:  Int J Mol Sci       Date:  2015-01-05       Impact factor: 5.923

Review 3.  Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease.

Authors:  Linda A Ban; Nicholas A Shackel; Susan V McLennan
Journal:  Int J Mol Sci       Date:  2016-03-14       Impact factor: 5.923

4.  Prognostic implications and procoagulant activity of phosphatidylserine exposure of blood cells and microparticles in patients with atrial fibrillation treated with pulmonary vein isolation.

Authors:  Huan Meng; Junjie Kou; Ruishuang Ma; Wenbo Ding; Yan Kou; Muhua Cao; Zengxiang Dong; Yayan Bi; Hemant S Thatte; Jialan Shi
Journal:  Mol Med Rep       Date:  2017-10-11       Impact factor: 2.952

5.  Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin.

Authors:  Carla Tripisciano; René Weiss; Tanja Eichhorn; Andreas Spittler; Thomas Heuser; Michael Bernhard Fischer; Viktoria Weber
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

Review 6.  Ultraviolet-A1 irradiation therapy for systemic lupus erythematosus.

Authors:  H McGrath
Journal:  Lupus       Date:  2017-05-08       Impact factor: 2.911

7.  Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation.

Authors:  Denis N Silachev; Kirill V Goryunov; Margarita A Shpilyuk; Olga S Beznoschenko; Natalya Y Morozova; Elizaveta E Kraevaya; Vasily A Popkov; Irina B Pevzner; Ljubava D Zorova; Ekaterina A Evtushenko; Natalia L Starodubtseva; Alexey S Kononikhin; Anna E Bugrova; Evgeniy G Evtushenko; Egor Y Plotnikov; Dmitry B Zorov; Gennady T Sukhikh
Journal:  Cells       Date:  2019-03-19       Impact factor: 6.600

8.  High intravascular tissue factor-but not extracellular microvesicles-in septic patients is associated with a high SAPS II score.

Authors:  Carolin Trepesch; Ramona Nitzsche; Aenne Glass; Bernd Kreikemeyer; Jochen K Schubert; Sonja Oehmcke-Hecht
Journal:  J Intensive Care       Date:  2016-05-23

9.  Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles.

Authors:  Morad-Rémy Muhsin-Sharafaldine; Sarah C Saunderson; Amy C Dunn; James M Faed; Torsten Kleffmann; Alexander D McLellan
Journal:  Oncotarget       Date:  2016-08-30

10.  Exercise during hemodialysis does not affect the phenotype or prothrombotic nature of microparticles but alters their proinflammatory function.

Authors:  Naomi Martin; Alice C Smith; Maurice R Dungey; Hannah M L Young; James O Burton; Nicolette C Bishop
Journal:  Physiol Rep       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.